Alpha Tau MedicalDRTS +4.67%28 Net Current Asset Value is $0.46 as of Mar. 2026, which is 89% below its 10-year median of 4.06. GuruFocus rates DRTS with a GF Score™ of 28/100. The stock has 3 warning signs investors should review. Among 943 Biotechnology companies, Alpha Tau Medical ranks worse than 89.93% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Alpha Tau Medical's net current asset value per share for the quarter that ended in Mar. 2026 was $0.46.
The historical rank and industry rank for Alpha Tau Medical's Net Current Asset Value or its related term are showing as below:
DRTS'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 2.37 Med: 4.06 Max: 28.74
Current: 28.74
During the past 7 years, the highest Price-to-Net-Current-Asset-Value Ratio of Alpha Tau Medical was 28.74. The lowest was 2.37. And the median was 4.06.
DRTS's Price-to-Net-Current-Asset-Value is ranked worse than 89.93% of 943
companies
in the Biotechnology industry
Industry Median: 4.96
vs DRTS: 28.74
Alpha Tau Medical (NAS:DRTS) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Alpha Tau Medical Net Current Asset Value Related Terms
Alpha Tau Medical Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Alpha Tau Medical's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DRTS vs ORIC, OLMA, KURA: Net Current Asset Value Comparison
For the Biotechnology subindustry, Alpha Tau Medical's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha Tau Medical Price-to-Net-Current-Asset-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alpha Tau Medical's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Alpha Tau Medical's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $0.46 mean?
Alpha Tau Medical (DRTS) has a Net Current Asset Value of $0.46 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Alpha Tau Medical and its competitors. This is 89% below median its historical median of 4.06. Over the past decade, Alpha Tau Medical's Net Current Asset Value has ranged from 2.37 to 28.74. According to the industry distribution chart, Alpha Tau Medical ranks #848 out of 943 companies in the Biotechnology industry, placing it in the top 89.9%.
Is Alpha Tau Medical's Net Current Asset Value too high?
Alpha Tau Medical's current Net Current Asset Value of $0.46 is 89% below median its 10-year median of 4.06. Over the past 10 years, this metric has ranged from a low of 2.37 to a high of 28.74. The Biotechnology industry median Net Current Asset Value is 4.96. Alpha Tau Medical's value of $0.46 is 90.7% below this industry median. Based on the distribution chart, Alpha Tau Medical ranks #848 out of 943 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Alpha Tau Medical has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Tau Medical's Net Current Asset Value compare to ORIC and OLMA?
According to the Biotechnology industry distribution chart, Alpha Tau Medical ranks #848 out of 943 companies for Net Current Asset Value. This places Alpha Tau Medical in the lower half of its industry. The industry median Net Current Asset Value is 4.96. Alpha Tau Medical's value of $0.46 is 90.7% below this benchmark. Historically, Alpha Tau Medical's own Net Current Asset Value has ranged from 2.37 to 28.74 over the past decade. While the company's 10-year median is 4.06 vs. the industry median of 4.96, Alpha Tau Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Biotechnology company?
The median Net Current Asset Value among Biotechnology companies is 4.96, based on 943 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha Tau Medical's current Net Current Asset Value of $0.46 is 90.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Alpha Tau Medical and its competitors. For the Biotechnology industry, the median Net Current Asset Value is 4.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha Tau Medical's current Net Current Asset Value is $0.46, which is 89% below median its own 10-year median of 4.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Tau Medical stock overvalued right now?
Alpha Tau Medical (DRTS) has a current Net Current Asset Value of $0.46. The current Net Current Asset Value is $0.46, which is 89% below median its 10-year median of 4.06 and 90.7% below the Biotechnology industry median of 4.96. Alpha Tau Medical's overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Alpha Tau Medical (DRTS), the current Net Current Asset Value is $0.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
28GF Score
Get the complete analysis for DRTS
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DRTS has been successfully added to your 
